Medical Consultation and Preoperative Evaluation - PowerPoint PPT Presentation

1 / 41
About This Presentation
Title:

Medical Consultation and Preoperative Evaluation

Description:

Medical Consultation and Preoperative Evaluation. Diane Doerner MD PhD ... His current medications include aspirin and lisinopril, 10 mg daily. ... – PowerPoint PPT presentation

Number of Views:1269
Avg rating:3.0/5.0
Slides: 42
Provided by: dianed
Category:

less

Transcript and Presenter's Notes

Title: Medical Consultation and Preoperative Evaluation


1
Medical Consultation and Preoperative Evaluation
  • Diane Doerner MD PhD
  • University of Washington Medical Center

2
Ten Commandments for Effective Consultations
  • Determine the question being asked

1. Determine the question being asked.
2. Establish the urgency of the consult.
3. Gather primary data.
4. Communicate as briefly as possible.
5. Make specific recommendations.
Goldman, L et al. Arch Int. Med (1983), 143 1753
3
Ten Commandments for Effective Consultations
  • Determine the question being asked

6. Provide contingency plans.
7. Understand your role in the process.
8. Offer educational information.
9. Communicate recommendations directly.
10. Provide appropriate follow-up.
Goldman, L. et al. Arch Int. Med (1983), 143 1753
4
  • One study looking at patterns of consultation
    among internists showed that 67 of consultations
    were for preoperative evaluation. In 12 of
    cases, the findings of the consultation resulted
    in a significant change in perioperative
    management in 7, surgery was delayed a
    decision was made to cancel surgery altogether in
    2 of cases.
  • Mollema, et al (2000) Neth J Med 567

5
Why Preoperative Evaluation?
  • 10 percent of the United States population
    undergoes non-cardiac surgery annually.
  • Over 8 million have known CAD or cardiac risk
    factors.
  • Over 50,000 will suffer a perioperative
    myocardial infarction.
  • The economic burden of these complications has
    been estimated at more than 20 billion
    annually.

6
  • The purpose of preoperative evaluation is not to
    give medical clearance, but rather to perform an
    evaluation of the patients current medical
    status make recommendations concerning the
    evaluation, management, and risk of cardiac
    problems over the entire perioperative period
    and provide a clinical risk profile that the
    patient, primary physician, anesthesiologist, and
    surgeon can use in making treatment decisions
  • Kim A. Eagle, FACC, Chair, ACC/AHA Task Force on
    Practice Guidelines for Perioperative
    Cardiovascular Evaluation for Noncardiac
    Surgery

7
Steps to Preoperative Evaluation
  • Surgical Risk Factors
  • Patient Risk Factors
  • Preoperative Testing
  • Perioperative Management

8
Case 1
  • A 74-year old man is referred to you for
    preoperative evaluation prior to undergoing a
    right total hip replacement. He is severely
    limited due to his osteoarthritis and can
    ambulate only limited distances in the home. His
    medical history is notable for CAD, for which he
    underwent an uncomplicated 3-vessel CABG 2 years
    ago. He has been symptom-free since. He has
    mild HTN and chronic renal insufficiency with a
    creatinine of 2.0 at baseline. Other than his
    CABG, he has no surgical history. His current
    medications include aspirin and lisinopril, 10 mg
    daily. His vital signs are notable for a BP of
    140/87, HR 88. Examination is essentially
    normal.
  • What are his surgical and medical risk factors?

9
Risk Type of ProcedureACC/AHA Guidelines
  • High risk (reported risk of adverse cardiac event
    gt5)
  • Emergency surgery
  • Aortic procedures
  • Peripheral vascular surgery
  • Prolonged surgical procedures associated with
    large volume shifts or high EBL

10
Risk Duration of Anesthesia
Reilly, et al. (1999) Arch Int Med 1592185
Percent Complications
Duration (hours)
11
Risk Type of ProcedureACC/AHA Guidelines
  • Intermediate Risk (reported cardiac risk lt 5)
  • Carotid endarterectomy
  • Head and neck surgery
  • Intraperitoneal and Intrathoracic
  • Orthopedic surgery
  • Prostate surgery

12
Risk Type of ProcedureACC/AHA Guidelines
  • Low risk (reported cardiac risk lt 1)
  • Endoscopic procedures
  • Superficial procedures
  • Cataract surgery
  • Breast surgery

13
Case 1
  • A 74-year old man is referred to you for
    preoperative evaluation prior to undergoing a
    right total hip replacement. He is severely
    limited due to his osteoarthritis, and can
    ambulate only limited distances in the home. His
    medical history is notable for CAD, for which he
    underwent an uncomplicated 3-vessel CABG 2 years
    ago. He has been symptom-free since. He has
    mild HTN and chronic renal insufficiency with a
    creatinine of 2.0 at baseline. Other than his
    CABG, he has no other surgical history. His
    current medications include aspirin and
    lisinopril, 10 mg daily. His vital signs are
    notable for a BP of 140/87, HR 88. Examination
    is essentially normal.
  • What are his surgical and medical risk factors?

14
Steps to Preoperative Evaluation
  • Surgical Risk Factors
  • Patient Risk Factors
  • Preoperative Testing
  • Perioperative Management

15
Patient Factors Exercise Tolerance
16
  • McPhail, et al (1988) J Vasc Surgery 760
  • 100 patients requiring vascular reconstructive
    surgery were evaluated preoperatively with
    treadmill testing or arm ergometry.
  • Patients able to achieve 85 of their maximal
    predicted heart rate had a 6 cardiac
    complication rate, whereas patients unable to
    achieve 85 MPHR had a 24 rate of complications
    (p 0.04)
  • Patients who had a positive stress test but
    achieved gt 85 MPHR had fewer cardiac
    complications.

17
1 MET the oxygen consumption (VO2) of a 70 kg,
40 y.o. man at rest3.5 cc/kg/minDuke Activity
Status Index
  • lt 4 METS gt 4 METS
  • Baking Ice skating
  • Slow dancing Moderate cycling
  • Golfing with a cart Walking 4 mph
  • Playing a musical instrument Heavy housework
  • Walking 2 3 mph Skiing

18
Risk Patient FactorsMajor Clinical Predictors
ACC/AHA Guidelines
  • Unstable coronary syndromes
  • Decompensated CHF
  • Significant arrhythmias
  • Severe valvular disease

19
Risk Patient FactorsIntermediate Clinical
PredictorsACC/AHA Guidelines
  • Mild angina pectoris
  • Prior MI
  • Compensated or prior CHF
  • Diabetes mellitus
  • Renal insufficiency

20
Risk Patient FactorsMinor Clinical
PredictorsACC/AHA Guidelines
  • Advanced age
  • Abnormal ECG
  • Rhythm other than NSR
  • Low functional capacity
  • History of CVA
  • Uncontrolled HTN

21
Case 1
  • A 74-year old man is referred to you for
    preoperative evaluation prior to undergoing a
    right total hip replacement. He is severely
    limited due to his osteoarthritis, and can
    ambulate only limited distances in the home. His
    medical history is notable for CAD, for which he
    underwent an uncomplicated 3-vessel CABG 2 years
    ago. He has been symptom-free since. He has
    mild HTN and chronic renal insufficiency with a
    creatinine of 2.0 at baseline. Other than his
    CABG, he has no other surgical history. His
    current medications include aspirin and
    lisinopril, 10 mg daily. His vital signs are
    notable for a BP of 140/87, HR 88. Examination
    is essentially normal.
  • What are his surgical and medical risk factors?
  • What preoperative testing is indicated?

22
Steps to Preoperative Evaluation
  • Surgical Risk Factors
  • Patient Risk Factors
  • Preoperative Testing
  • Who
  • How
  • Perioperative Management

23
Cardiac Testing Resting ECG
  • Class I (definite indication)
  • Recent ischemic symptoms
  • Major / intermediate clinical predictors and high
    or intermediate risk procedure
  • Class II (probably warranted)
  • Asymptomatic diabetics
  • History of cardiac revascularization
  • Asymptomatic man gt 45 yo or woman gt 55 yo
  • Prior hospitalization for cardiac causes
  • Class III (not indicated)
  • Asymptomatic patient low risk procedure

24
Echocardiography
  • Class I (definite indication)
  • Current or poorly-controlled CHF unless prior
    studies have documented severe ventricular
    dysfunction
  • Class II (probably warranted)
  • Prior CHF and no recent evaluation
  • Dyspnea of unknown etiology
  • Evidence of significant valvular disease
  • Class III (not indicated)
  • Routine testing of ventricular function in
    asymptomatic patients without a prior history of
    CHF

25
emergency
Need for non-cardiac surgery
O. R.
elective
N
Y
Recurrent S/sx?
Recent cardiac revascularization ?
N
Y
Recent cardiac evaluation?
Favorable result?
N
Unfavorable result or change in sx?
Clinical Predictors
ACC/AHA Guidelines
26
Clinical Predictors
Major Clinical Predictors?
Intermediate or Minor Clinical Predictors?
Further evaluation
Exercise Tolerance?
Poor Exercise Tolerance lt 4 METS
Good Exercise tolerance gt 4 METS
27
Minor or No Clinical Predictors
Poor Exercise Tolerance lt 4 METS
Good Exercise tolerance gt 4 METS
High risk procedure
Intermediate or low risk procedure
Non-invasive cardiac testing
Low risk
High risk
O. R.
Further evaluation
28
Intermediate clinical predictors
Poor Exercise Tolerance lt 4 METS
Good Exercise tolerance gt 4 METS
High risk procedure
Intermediate risk procedure
Low risk procedure
Non-invasive cardiac testing
High risk
Low risk
O. R.
Further evaluation
29
Preoperative Stress Testing
Y
Major clinical predictors?
Further evaluation
N
N
2 or more of the following Intermediate
clinical predictors Poor exercise
tolerance lt 4 METS High risk surgery
O.R.
Y
Patient ambulatory and can exercise?
Test ONLY if outcome will impact management
30
Patient ambulatory and can exercise?
Y
N
Male, normal ECG at rest?
Bronchospasm? Second degree AV block? Theophylline
dependent? Valvular dysfunction?
N
Y
ECG ETT
ETT Echo or Perfusion scan
Y
N
Pharmacological Echo or Perfusion Scan
Prior symptomatic arrhythmia? Poor Echo
window? Extreme blood pressure?
Hx Arrhythmias? Severe HTN?
N
Y
Y
N
Persantine or Adenosine Perfusion Scan
Dobutamine Echo or Perfusion Scan
Further evaluation
31
Perioperative ManagementPercutaneous
Intervention (PCI)
  • No randomized trials have demonstrated benefit of
    balloon angioplasty or stenting in decreasing
    cardiac risk before non-cardiac surgery.
  • Posner KL, et al (1999) Anesth Analg 89553
  • Retrospective cohort study comparing patients
    undergoing preoperative PTCA, patients with known
    CAD that did not undergo PTCA preoperatively, and
    normal controls (no known CAD).
  • No reduction in early postoperative MI or death
    in patients who underwent PTCA.
  • Study was not controlled for severity of CAD,
    differences in medical management between the
    groups, or comorbidity.

32
Case 1
  • A 74-year old man is referred to you for
    preoperative evaluation prior to undergoing a
    right total hip replacement. He is severely
    limited due to his osteoarthritis, and can
    ambulate only limited distances in the home. His
    medical history is notable for CAD, for which he
    underwent an uncomplicated 3-vessel CABG 2 years
    ago. He has been symptom-free since. He has
    mild HTN and chronic renal insufficiency with a
    creatinine of 2.0 at baseline. Other than his
    CABG, he has no other surgical history. His
    current medications include aspirin and
    lisinopril, 10 mg daily. His vital signs are
    notable for a BP of 140/87, HR 88. Examination
    is essentially normal.
  • What are his surgical and medical risk factors?
  • What preoperative testing is indicated?
  • What measures would you initiate preoperatively
    to optimize his risk?

33
Steps to Preoperative Evaluation
  • Surgical Risk Factors
  • Patient Risk Factors
  • Preoperative Testing
  • Who
  • How
  • Perioperative Management

34
Perioperative Management Beta-Blockers
  • Poldemans D, et al (1999) NEJM 3411789
  • 112 patients identified to be at increased
    cardiac risk (positive dobutamine Echo)
    preoperatively were randomized to treatment with
    bisoprolol or placebo.
  • Cardiac complications and cardiac death was
    significantly less in the treatment group
    (p0.02)
  • Bisoprolol 3.4
  • Placebo 17.0
  • Wallace A, et al (1998) Anesthesiology 887
  • 200 patients undergoing general surgery were
    randomized to 7 day treatment with Atenolol or
    placebo.
  • Patients treated with Atenolol had significantly
    fewer episodes of ischemia by continuous
    monitoring (p0.03)

35
Perioperative Management Cardiac Devices
  • Pacemakers
  • Current generated through use of electrocautery
    can interfere with function of implantable
    devices
  • Temporary reset to a VVI mode
  • Increase in pacing rate due to activation of
    rate-responsive sensor
  • Failure to sense or capture

Recommendations Obtain information
preoperatively regarding the pacer manufacturer,
model and serial number, battery status,
and most recent interrogation. If the
pacer is programmed in a rate-responsive mode,
this feature should be inactivated
preoperatively. If a patient is
pacer-dependent, temporary reset to a non-sensing
mode preoperatively may be indicated.
Operative techniques to minimize stray current
(short electrocautery strokes, placement
of electrocautery grounding pad away from pacer
pocket).
36
Perioperative Management Cardiac Devices
  • Implantable Defibrillators
  • Can fire due to activation by stray electrical
    current from electrocautery use
  • Must be programmed OFF preoperatively and then
    reactivated postoperatively
  • Place defibrillator patches intraoperatively
  • Telemetry monitoring is indicated postoperatively
    until the AICD has been reactivated.

37
Perioperative ManagementBlood Thinners
  • Aspirin (general indication) 14 days
  • Aspirin (TIA / CVA / MI) 7 days
  • NSAIDS 3-7 days
  • Cox II inhibitors --------
  • Clopidogrel (Plavix) 4-7 days
  • Persantine 7 days
  • Coumadin variable
  • Herbal remedies 14 days
  • (Gingko, Ginseng, Garlic, Feverfew)

38
Perioperative Management of Selected Drugs
39
Case 2
  • A 60-year old woman is referred to you for
    preoperative evaluation prior to undergoing a
    right femoral-popliteal bypass procedure. She
    develops symptoms of claudication at about 1
    block but states she can walk 2 blocks if need
    arises. Her medical history is otherwise notable
    for obesity, hyperlipidemia and type II diabetes,
    diagnosed 6 years ago and well controlled on oral
    medications. ROS is significant for infrequent
    atypical CP. Her current medications include
    glucophage and atorvastatin and cilostazol. Her
    vital signs are normal. Examination is only
    remarkable for a cool right lower extremity with
    a non-palpable dorsalis pedis pulse.
    Cardiopulmonary examination is normal and there
    are no bruits.
  • What are her surgical and medical risk factors?
  • What preoperative testing is indicated?
  • What measures are needed perioperatively?

40
Preoperative management of diabetics
  • General anesthetic produces relative insulin
    hyposecretion and resistance due to changes in
    neuroendocrine balance (increased production of
    ACTH, catecholamines, GH, and glucagon).
  • Postoperative factors such as inability to eat or
    absorb oral medications, use of steroids,
    hyperalimentation or tube feeds can affect
    glycemic control.
  • Perioperatively
  • Assess glycemic control preoperatively.
  • Oral hypoglycemics can generally be continued up
    until the time of surgery but should not be taken
    on the morning of the procedure. Metformin
    should be held for 48 hours postoperatively, and
    then restarted only if renal and hepatic function
    are stable.
  • The dose of intermediate and long-acting insulins
    should be reduced on the night prior to surgery.
  • For long or complicated procedures in patients
    requiring insulin, intravenous insulin should be
    used in the immediate perioperative period. For
    short procedures, it may be possible to either
    delay the use of morning insulin, or use a
    fraction of the normal dose of intermediate-acting
    insulin.

41
THANKS
Write a Comment
User Comments (0)
About PowerShow.com